In terms of patients to follow-up and patients dropping out, the studies did not show any significant differences in clinical profiles.
In case of drop-outs, the study will include new blocks of six patients to ensure randomisation and balance between the two groups.
After exclusions, due to eligibility or participant drop-out, the studies included 3724 participants in their analyses.
There was four drop outs from the study over the three years.
No drop outs during the study are expected.
Three hospitals had dropped out from the study after they were included in the study.
The surprising main reason for dropping out of the study was the frequent emigration from Lithuania.
In these cases, the participants were asked the reason for dropping out of the study.
None of the patents dropped out during the study.
Dropout analysis was made for doctors who dropped out from the study after the second wave.
No families dropped out of the study during the 2-month observation period.
